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Abstract 
 
Cellular uptake of vector peptides used for internalization of hydrophilic molecules into cells 
is known to follow two different pathways: direct translocation of the plasma membrane and 
internalization by endocytosis followed by release into the cytosol. These pathways differ in 
their energy dependence. The first does not need metabolic energy while the second requires 
metabolic energy. Herein we used erythrocytes and plasma membrane vesicles to study 
membrane perturbations induced by the cell penetrating peptide penetratin. The results show 
that cell penetrating peptides are able to be internalized by two metabolic energy-independent 
pathways: direct crossing of the plasma membrane and endocytosis-like mechanisms. The last 
mechanism involves the induction of membrane negative curvature resulting in invaginations 
that mimic the endosomal uptake in the absence of ATP. This new mechanism called 
"physical endocytosis" or "self-induced endocytosis" might explain different data concerning 
the independence or dependence on metabolic energy during cellular uptake and reveals the 
autonomous capacity of peptides to induce their internalization. 
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1. Introduction 
Cell penetrating peptides (CPPs) and protein transduction domains (PTDs) have been 
developed to introduce active molecules into cells (Mae and Langel, 2006; Murriel and 
Dowdy, 2006). The understanding of the uptake mechanisms of CPPs is essential to develop 
more efficient vectors for therapeutic purposes. Penetratin, a peptide derived from the third 
helix of Antennapedia transcription factor homeodomain was described, with Tat, as the first 
vectors to successfully carry active molecules inside cells (Joliot et al., 1991; Perez et al., 
1994). 
It has become clear that CPPs cellular delivery results from both: direct plasma membrane 
crossing, and internalization by endocytic routes with the posterior endosomal release into the 
cytosol (Duchardt et al., 2007; Lundin et al., 2008). Moreover, it was shown that cationic and 
amphipathic peptides use different endocytic routes for cellular uptake (Lundin et al., 2008) 
indicating a sequence-structure dependence for the mechanism of internalization. The two 
"mechanisms" can be separated according to their metabolic energy dependence. The energy-
dependent mechanisms are usually associated with different types of endocytosis, and the 
energy-independent mechanisms with the direct translocation through the phospholipid 
bilayer. Recently, it was shown that at low peptide concentration (1 μM) penetratin was 
mainly internalized by direct plasma membrane translocation whereas at higher concentration 
(10 μM) a GAG-mediated endocytic pathway was responsible of cellular uptake (Alves et al., 
2011). However, data from cellular studies are frequently ambiguous for two reasons. First, it 
must be considered that a peptide able to translocate directly through the plasma membrane, is 
able to associate to other internal membranes. Therefore, these punctuated structures observed 
by optical microscopy can be interpreted as endosomes. Secondly, it is difficult to completely 
block the metabolic energy at a physiological temperature to be sure that penetration follows 
only direct plasma membrane translocation. 
For these reasons, several membrane models have been used for biophysical studies and 
membrane crossing quantification. CPPs seem to be able to translocate through the membrane 
of giant vesicles (GUV of several µm) (Persson et al., 2004a; Thoren et al., 2000), but unable 
to cross the membrane of small vesicles (100 nm) unless an electrostatic (or pH) driving 
membrane potential is present (Madani et al., 2011; Terrone et al., 2003). Membrane models 
3 
 
also allowed the demonstration of peptide induced phospholipid phase separation and 
membrane deformations such as tubulation by induction of negative curvature (Alves et al., 
2008; Lamaziere et al., 2007; Lamaziere et al., 2006; Lamaziere et al., 2008). However these 
models are quite simple compared to a biological membrane with complex lipid composition, 
containing different proteins, glycosylated molecules and presenting lateral and transverse 
asymmetries. 
Elaborated cellular models for the plasma membrane are therefore required. Recently, several 
groups showed that giant vesicles from the plasma membrane are useful models for cellular 
studies. These vesicles, called giant plasma membrane vesicles (GPMVs) or plasma 
membrane spheres (PMS), depending on the method used for their production, are void of 
cellular organelles and their spherical morphology is adapted to observe peptide induced 
membrane deformations. Their overall composition represents that of the plasma membrane. 
They don't have cytoskeleton elements, are able to experiment protein and phospholipid phase 
separation (Baumgart et al., 2007; Keller et al., 2009; Lingwood et al., 2008) and importantly 
for this study, they are depleted of metabolic energy. Recently these plasma membrane 
derived vesicles were used to study the binding kinetics and penetration of several CPPs 
(Amand et al., 2011; Saalik et al., 2011). 
In this study we used PMS as a model to observe the interaction of penetratin and other basic 
peptides with the plasma membrane. We show that penetratin is able to use two metabolic 
energy-independent pathways to be internalized into PMS. The first mechanism is the well 
known direct translocation of the plasma membrane, and the second involves the induction of 
endocytic-like membrane invaginations ("physical endocytosis" or "self-induced 
endocytosis"). The importance of these mechanisms for physiological cell penetration is 
discussed. 
 
2. Materials and methods 
2.1. Materials. 
The peptides penetratin (Pen: RQIKIWFQNRRMKWKK), Carboxyfluorescein-labelled 
penetratin (CF-Pen), nona-arginine (R9), RW9 (RWRRWWRRW) and RW16 
(RRWRRWWRRWWRRWRR) where synthesized and purified as previously described 
(Lamaziere et al., 2007; Lamaziere et al., 2008). DiI (C16) was from Invitrogene and di-4-
ANEPPDHQ was obtained from Dr Leslie M. Loew (Connecticut, USA). 
 
2.2. Erythrocytes ghosts and erythrocyte fusion. 
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8.5 ml of human blood were mixed with the anticoagulant ACD. Erythrocytes were washed 
three times in buffer A (HEPES 10 mM pH 7.4, NaCl 150 mM) by successive centrifugations 
at 150 x g for 10 minutes. 
The preparation of erythrocytes ghosts was performed as described by Steck and Kant (Steck 
and Kant, 1974). Briefly, concentrated erythrocytes were lysed by addition of 40 volumes of 
lysis buffer (Sodium phosphate 5 mM, pH 8). The ghosts were recovered by centrifugation at 
22 000 x g for 20 minutes and washed three times with lysis buffer. 
Erythrocytes fusion was performed by electrofusion. 50 µl of erythrocytes were added to an 
electroporation cuvette (1 mm) containing 100 µl of PBS buffer and they were compacted by 
centrifugation at 100 x g for 2 minutes. Electrofusion was performed by two 0.15 ms 
impulsions of 1100 V spaced by 5 s with a Bio-Rad electroporator. The electrofused 
erythrocytes were conserved at 4°C until use. 
 
2.3. Plasma membrane spheres (PMS). 
MDCK cells were cultured in DMEM media in standard conditions as previously described 
(Ayala-Sanmartin et al., 2004). Briefly, The cells were incubated in DMEM medium 
supplemented with decomplemented foetal calf serum (10%) and antibiotics (penicillin and 
streptomycin) at 37°C in humidified atmosphere and CO2 (5%) in 75 cm
2 flasks. The plasma 
membrane spheres were obtained by the method described in (Lingwood et al., 2008). Prior to 
PMS induction, near confluence cell cultures were washed with PBS. Then, to induce the 
swelling of the plasma membrane, the cultures were incubated overnight with 1 ml of PMS 
buffer (1.5 mM CaCl2, 1.5 mM MgCl2, 5 mM HEPES, 1 mg ml
-1 glucose in PBS pH 7.4). 
After PMS formation, 1 ml of PMS buffer was added and the cells were agitated gently for 
one minute. Then, the 2 ml of buffer containing the PMS was recovered and centrifuged in an 
eppendorf tube at 1000 rpm for 15 minutes. The PMS were resuspended in 100 µl of PBS and 
conserved at 4°C for several hours. The data presented in this work was performed with 8 
different PMS preparations. 
 
2.4. PMS and erythrocytes treatments and incubations. 
All preparations for microscopic observation were performed on µ-slide 8 well slides from 
Ibidi containing 160 µl of freshly prepared erythrocytes ghosts, fused erythrocytes or PMS. 
For DiI labelling, DiI stock solution (500X) in ethanol was diluted in PBS. Then, 8 µl were 
added for a final concentration of 10 µM. For labelling with di-4-ANEPPDHQ, a stock 
solution (200 mM) in ethanol was diluted in PBS. Then, 20 µl were added for a final 
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concentration of 5 µM. Unless specified, the peptides Pen, CF-Pen, RW9, R9 and RW16 were 
added in 10 µl for a final concentration of 10 µM. 
 
2.5. Phase contrast microscopy. 
The phase contrast microscopy was performed with a Zeiss Axiovert 2000M inverted 
microscope. Images were captured with a CCD camera (Cool SNAP HQ) controlled with 
Metamorph software (Roper Scientific). 
 
2. 6. Confocal microscopy. 
All the fluorescence confocal images were acquired with a TCS SP2 laser-scanning spectral 
system (Leica, Wetzlar, Germany) attached to a Leica DMR inverted microscope (Platform 
Imagerie cellulaire et tissulaire, IFR65). Optical sections were recorded with a 63/1.4 or 
100/1.4 immersion objectives. Laser scanning confocal images were collected, and analyzed 
using the online Scan Ware software. Figures compilation was accomplished using ImageJ 
software (NIH). For CF-Pen and di-4-ANEPPDHQ, the samples were excited at 488 nm (Ar 
ion laser). The fluorescence emission was collected using band-pass of 500-540 nm for CF-
Pen and 610-650 nm for di-4-ANEPPDHQ. For the experiments using CF-Pen and di-4-
ANEPPDHQ simultaneously the laser intensity and the PMTs were set to avoid the detection 
of the CF-Pen at 610-650 nm by using a standard with CF-Pen and no di-4-ANEPPDHQ. 
For the experiments with DiI and CF-Pen, the samples were sequentially excited. Firstly by 
excitation at 488 nm for CF-Pen, and collecting fluorescence emission using a band-pass of 
500-560 nm. A second excitation for DiI (543nm with a HeNe laser) was followed, and the 
emission was collected with a band-pass of 560-650 nm. In this case the excitation of each 
fluorophore was independent precluding bleed-through between channels. 
 
3. Results 
In precedent studies we demonstrated that several CPPs are able to induce invaginations in 
simple and pure lipid model membranes (GUV) (Lamaziere et al., 2007; Lamaziere et al., 
2009; Lamaziere et al., 2008). We called this phenomenon "physical endocytosis". Herein, we 
show experiments demonstrating that these peptides are also able to deform cellular plasma 
membranes. The cellular plasma membrane is morphologically very complex and dynamic.  
The cytosol is filled with intracellular membranous structures complicating the interpretation 
of microscopic observations. Therefore, to study CPP-membrane interactions on a spherical 
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plasma membrane with no internal membranous organelles, we decided to use erythrocytes 
and Plasma Membrane Spheres (PMS). 
 
3.1. Cell penetrating peptides interaction with erythrocytes. 
Erythrocytes are membrane organelles-free cells but are small and discoid in shape. 
Therefore, to facilitate microscopic observation of spherical structures, in a first series of 
experiments we used erythrocytes ghosts stained with the fluorescent molecule di-4-
ANEPPDHQ. This dye is not fluorescent in aqueous solution and has been used to 
characterize membrane fluidity (Jin et al., 2006). The erythrocytes ghosts were labelled 
homogeneously with the probe. Figure 1a and c show confocal slices of ghosts with diameters 
close to 4-5 μm. The most evident phenomenon observed after the addition of penetratin and 
nona-arginine (R9) to the ghosts was their aggregation (Fig. 1b). Membrane aggregation 
induced by several CPPs has been previously reported in model membranes (Lamaziere et al., 
2007; Persson et al., 2004b; Persson et al., 2001). The ghosts are quite small and did not 
attach to the surface of the chamber making their observation and monitoring difficult by 
confocal microscopy. Nevertheless, we were able to observe some internal membranes in the 
ghosts incubated with R9 (Figure 1d). In order to improve the microscopic observation, we 
increased the size of the erythrocytes by electrofusion. The efficiency of erythrocytes fusion 
was low and their shape was quite variable. They present very frequently complex forms with 
bud like structures which are probably rests of fused erythrocytes unable to acquire the 
spherical shape (Fig. 1e). Figure 1f shows a 3D reconstruction from confocal microscopy 
slices in which a tubular like structure was formed in fused erythrocytes incubated with the 
peptide penetratin. However, the low efficiency of erythrocyte fusion and their particular 
morphology resulted in ambiguity of interpretation of some membranous structures associated 
with the plasma membrane. Then, we used the Plasma Membrane Spheres (PMS) as cellular 
model for further analysis. 
 
3.2. Penetratin crosses the plasma membrane bilayer of PMS. 
Plasma membrane derived vesicles have been partially characterized by several groups. Their 
molecular composition is very close to that of the parent cells. They contain membrane 
proteins such as Thy1, Lyn and FcɛRI, IP17, and several transmembrane and GPI anchored 
proteins. The phosphatidylcholine and phosphatidylethanolamine contents are unperturbed but 
phosphatidylserine asymmetry is partially lost. They are able to experiment membrane 
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domains separation, and they conserve their impermeability. They are depleted in both, ATP 
and cortical actin (Baumgart et al., 2007; Levental et al., 2011; Lingwood et al., 2008). 
In a first series of experiments we incubated PMS with fluorescent penetratin to a final 
concentration of 5 μM. In this conditions, and as previously described by other groups using 
GPMVs (Amand et al., 2011; Saalik et al., 2011), we observed that penetratin was 
internalized into the PMS (Figure 2). Careful analysis of confocal images showed that besides 
a diffuse labelling (Fig. 2a-c), spots of fluorescence associated to the membrane were 
observed (Figure 2d-f). The diffuse signal in the vesicular lumen demonstrates that penetratin 
is able to cross the plasma membrane and accumulates inside (Fig 2a-c). This accumulation 
was observed previously for different peptides (Amand et al., 2011; Saalik et al., 2011) and is 
probably due to peptide association to negatively charged macromolecules present in the 
lumen such as proteins and RNA. This association precludes the backward diffusion to the 
extracellular milieu resulting in accumulation in the cytosolic compartment. The 
characterization of CPP internalization on GPMVs was published elsewhere (Amand et al., 
2011; Saalik et al., 2011) thus, we focused our experiments on the characterization of the 
membrane deformations induced by penetratin (Fig. 2d-f). 
 
3.3. Penetratin induces membrane invaginations in PMS. 
Considering that CPPs internalization by membrane crossing was observed at 1-5 μM 
concentrations for GPMVs (Amand et al., 2011; Saalik et al., 2011) and cells (Alves et al., 
2011), but the glycan-mediated endoctosis was observed at 10 μM penetratin (Alves et al., 
2011), we decided to increase the peptide concentration to 10 μM for the next experiments. 
PMS were observed by phase contrast microscopy in the absence or presence of penetratin. 
After peptide addition, we observed a time-dependent accumulation of dark structures inside 
the vesicles (Figure 3a). To better characterize these structures we prepared di-4-
ANEPPDHQ-labelled PMS. Figure 3b is a stack of confocal slices of control PMS showing 
that PMS are free of internal membranes. The advantage of this probe is that the membrane 
and the peptide are excited at the same time and the emission signals are captured 
simultaneously. Figures 3c and 3d show the accumulation of penetratin in structures 
originated in the plasma membrane that grew towards the vesicular lumen (see also 
supplementary Fig S1). The confocal 3D projections of PMS incubated with penetratin in 
supplementary videos S1 and S2 illustrate the high number and length of these penetratin 
induced invaginations. The co-localisation of the peptide with the membrane was revealed by 
the light turquoise colour (Fig. 3c and 3d). However, to avoid the risk of imaging artefacts 
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when capturing images from penetratin and membranes simultaneously, in a second series of 
experiments we labelled the membranes with the fluorescent probe DiI before the incubation 
with CF-Pen (supplementary video S3). In these conditions excitation and emission of each 
probe were independent. As shown in figure 3e at short times of penetratin incubation, the 
membrane tubes and penetratin label correlated. At longer times the membrane tubes growth 
towards the centre of the vesicle allowing movement inside the PMS lumen. Due to the delay 
of images capture, movements inside the vesicle made difficult to observe a perfect co-
localization of penetratin with membranes (Supplementary video S4). However, co-
localisation was clear for many of the internal membrane-peptide structures (Figure 3f, see 
also supplementary figure S1). The penetratin induced membrane invaginations of the PMS 
membranes was observed in PMS with or without the two probes indicating that the formation 
of invaginations depends on the peptide and not on the probes used (Figure 4). 
 
3.4. Other small CPPs are able to induce membrane invaginations. 
Three other arginine rich CPPs were tested for their capacity to induce membrane 
invaginations on PMS; the small positively charged peptide nona-arginine (R9), and two 
amphipathic peptides of different length (RW9 and RW16). The long amphipathic peptide 
RW16 did not induce internal membrane tubulation. Figure 5 shows images of internal tubes 
observed after incubation with R9 and the short amphipathic peptide RW9. Interestingly, the 
form of these tubes was sometimes different from those observed with penetratin. The 
membrane structures observed after penetratin incubation were always compact and twisted. 
After incubation with R9 and RW9 we observed both, compacted membrane tubes and other 
invaginations forming well shaped large tubes (Fig. 5). As for penetratin, the invaginations 
were observed about 20 minutes after peptide addition. 
 
4. Discussion 
In this paper, we studied the internalization and the morphological membrane perturbations of 
basic peptides on plasma membrane spheres (PMS). Plasma membrane vesicles have been 
obtained by different cellular treatments. The difference between GPMV and PMS resides in 
the method used for their production. Giant plasma membrane vesicles (GPMV) are obtained 
by treatments with chemical agents such as formaldehyde and DTT, acetone or ethanol 
(Baumgart et al., 2007), while PMS are obtained by long incubation of cells with PBS-glucose 
without addition of other organic molecules. To avoid the risk of lipid solubilisation by 
organic solvents or protein modifications by formaldehyde and DTT, we preferred to use 
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PMS obtained with a buffer free of organic chemicals. The experiments presented here 
demonstrate an endocytic-like mechanism of internalization for penetratin into biological 
vesicles. The capacity of penetratin to directly translocate into GPMVs has been recently 
shown by two different groups (Amand et al., 2011; Saalik et al., 2011) and was corroborated 
herein with PMS. In both cases, the authors showed that the GPMVs conserve their 
membrane integrity. 
Our experiments showed direct membrane translocation at low peptide concentration (1-5 
μM) and tube formation at higher concentration (10 μM). However, the performed confocal 
experiments are not adapted for the fine study of the concentration dependence of peptide 
activity. The vesicles must be attached to the slide and the peptide is added concentrated in a 
small volume to avoid movement of the vesicles. The peptide diffuses from one point on the 
well towards the bottom were the vesicles are located. Therefore, the local concentration close 
to the vesicles when membrane translocation and tubular growth starts is not precisely 
measured. These arguments are also valid for the time dependency study because the peptide 
action on the membrane depends also on the peptide diffusion time. However, the time for 
microscopic observation of peptides effects shown here are in the same range (about 10 
minutes after peptide addition) that those previously published for the GPMVs (Amand et al., 
2011; Saalik et al., 2011). 
Herein we describe a novel mechanism for CPP internalization on plasma membrane vesicles 
involving membrane invaginations. With R9 and penetratin, membrane invaginations in 
erythrocyte ghosts and fused erythrocytes were observed although at a very low frequency. 
Penetratin, R9 and RW9 peptides were also able to induce membrane invaginations on PMS 
suggesting that this mechanism is shared by some basic penetrating peptides in plasma 
membranes of different cell types. However, the membrane invaginations were not observed 
with the peptide RW16 indicating that all the basic peptides did not share this property. The 
absence of invaginations induced by RW16 could be related to its size and capacity to form a 
long amphipathic helix (16 residues) that favours its insertion into the membrane and the 
formation of small pores (Lamaziere et al., 2007). The capacity of basic CPPs to form tubes 
was previously observed in membrane models (Lamaziere et al., 2007; Lamaziere et al., 2010; 
Menger et al., 2003) but to our knowledge this is the first time that the CPP induced 
tubulation is observed with biological membranes. However, this capacity to invaginate 
membranes has been observed for other peptides and protein domains such as the shiga toxin 
(Romer et al., 2007) and I bar domains (Saarikangas et al., 2009). Membrane invaginations 
are due to negative curvature induction. Peptides' capacity to favour membrane negative 
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curvature was previously demonstrated in GUVs (Lamaziere et al., 2007; Lamaziere et al., 
2009; Lamaziere et al., 2008). For penetratin and peptides such as R9 negative curvature 
would be produced by compaction of phospholipids after the association of arginine residues 
with the phospholipids head groups on the external leaflet of the vesicles as previously 
suggested for giant unilamellar vesicles (Lamaziere et al., 2007). A second possible 
mechanism to induce negative curvature would be by removing lipids from the outer layer of 
the membrane. However, this mechanism seems improbable and requires the formation of 
micelles-like structures originated from the outer leaflet of the bilayer.  Once invaginations 
are initiated, changes in membrane tension would allow tubes to grow inside the vesicles 
(Lamaziere et al., 2010). The shape of invaginations seemed to be different for the different 
peptides. R9 and RW9 showed thicker tubes and at low frequency compared to those induced 
by penetratin that were more frequent, thinner and apparently twisted. This would certainly be 
related to the peptide sequence and therefore to the structural capacities of the different 
peptides. R9 and RW9 are very basic and short, RW9 is amphipathic while penetratin is 
longer, structurally more complex and conformationally versatile (Caesar et al., 2006; 
Magzoub et al., 2002; Magzoub et al., 2001; Maniti et al., 2010; Persson et al., 2004b). It is 
tempting to speculate that penetratin bind the membranes by different points on its surface 
favouring membrane bridging that results in the extension of thinner and twisted tubes. 
 
In living cells a tubular growth in such a high number and membrane extension has never 
been observed. This is probably due to two important factors. First, the observed tubular 
growth is probably due to the absence of the cortical cytoskeleton in the PMS. This fact would 
allow the initial step necessary for membrane flexibility and negative curvature induction. The 
cortical cytoskeleton which is dynamically stable in erythrocytes might block membrane 
invaginations explaining the very low frequency of tubes observed in fused erythrocytes and 
ghosts. The second factor is that in a living cell, after membrane invagination, the endocytic 
vesicles are rapidly cut from the plasma membrane by dynamin. This step is not present in the 
PMS and therefore, the tubular extension of the membrane invaginations is allowed. These 
explanations are supported by the work with shiga toxin showing the stabilization of 
membrane invaginations in mutants with no dynamin or after blocking actin function (Romer 
et al., 2007). 
At 10 μM peptide concentration, we rarely observed diffuse fluorescent penetratin in the 
cytosol at the same time that membrane invaginations. In cells it has been shown that CPPs 
are internalized by direct membrane translocation at low concentration (1 μM) and that at 
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higher concentration they are preferentially internalized by GAG-mediated endocytosis 
(Alves et al., 2011). In our conditions (10 μM), penetratin favoured physical endocytosis 
indicating that at high concentrations peptide-peptide interactions at the membrane surface are 
necessary to form the tubes. Our observations also indicate that the peptide did not cross the 
membrane of tubes. Two related factors might be involved in the apparent absence of 
membrane translocation from tubes; curvature and pH gradient. It has been shown that 
membrane translocation depends on the size (curvature) of the vesicles. In almost flat 
membranes such as GUVs of several µm in diameter (10-30 µm), penetratin is able to cross 
the membrane (Persson et al., 2004a; Thoren et al., 2000). In highly curved membranes (100 
nm LUVs) the efficient penetration requires ionic potential or pH acidification (Madani et al., 
2011; Terrone et al., 2003). Therefore, the absence of acidification in highly curved structures 
would decrease the probability of peptide membrane translocation. In metabolically normal 
cells, CPP escape from the endosomes is thought to be driven by the acidification of the 
endosome. Therefore when "physical endocytosis" occurs in normal cells, the posterior traffic 
of the vesicles and their fusion with endosomes would result in acidification of the lumen and 
peptide release into the cytosol. 
Does Physical endocytosis occur in living cells? We tentatively suggest that the response to 
this question is yes. The intrinsic structural capacity of the peptide to induce negative 
curvature might be independent of the metabolic endocytosis. The independence of the 
peptide uptake and several endocytic pathways is illustrated by the fact that TAT uptake does 
not depend on clathrin, caveolae or dynamin (Wadia et al., 2004). However, passive 
internalisation of membrane associated peptide during different endocytic processes is not 
excluded. If these hypotheses are true, we can predict that besides the normal dynamic 
movements of the plasma membrane, the peptides would be able to provoke inward 
vesiculation resulting not only in peptide internalization but also in an increase of the rate of 
endocytosis of other molecules. This prediction is supported by the fact that, the CPPs TAT 
and penetratin increase the neutral dextran fluid phase cellular uptake (Amand et al., 2008; 
Wadia et al., 2004). 
 
5. Conclusion 
In conclusion, our data show that "physical" or "self-induced" endocytosis is a novel 
mechanism for penetratin cellular internalization. This mechanism is defined as the capacity 
of a peptide to produce endosome like invaginations without participation of metabolic 
energy. As shown in the schematic representation of figure 6, the main differences between 
12 
 
the model of physical endocytosis and the biological endocytic pathways is the absence of a 
metabolic energy-dependent driving force for the induction of inward vesiculation. The 
driving force for physical endocytosis results from the peptide self-capacity to induce 
negative curvature.  
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Figure legends 
 
Figure 1. Plasma membrane perturbations in erythrocytes incubated with cell penetrating peptides. 
Erythrocytes were stained with the membrane probe di-4-ANEPPDHQ, and incubated with R9 or 
penetratin. Confocal slices of erythrocytes ghosts before (a) and 15 minutes after R9 addition (b). 
Notice the peptide mediated ghosts' aggregation. Confocal slices of an erythrocyte ghost (c) and a 
ghost 20 minutes after R9 addition (d). Notice the tubular structure (arrow) inside the erythrocyte 
ghost. Projections of confocal slices stack of two fused erythrocytes (e). Notice the bud-like structures 
(arrows) in the upper fused erythrocyte. Projections of confocal slices stack of two fused erythrocytes 
incubated with penetratin (f). A tube inside the fused erythrocyte at the left is shown (arrow). Scale 
bars a, b, e and f; 10 µm, c and d; 5 µm. 
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Figure 2. Direct translocation of penetratin through the plasma membrane of PMS.  Confocal slices of 
PMS showing penetratin internalization into PMS incubated with 5 μM of CF-Pen for 20 (a), and 25 
minutes (b). (c) Shows the density profile of the line crossing the PMS in (a). Notice the accumulation 
of homogeneous fluorescence in the lumen of the vesicle. PMS incubated with CF-Pen for 40 (d) and 
35 minutes (e). (f) Shows the density profile of the line crossing the PMS in (d). Notice the 
inhomogeneous fluorescence in the lumen of the vesicle.PMS labelled with DiI in red and CF-Pen in 
green. Images are representative of two independent experiments. Arrows indicate spots of fluorescent 
penetratin associated with membranes, arrowheads the corresponding fluorescence of the section in (d) 
and the profile (f). Scale bars 10 µm. 
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Figure 3. Penetratin induces membrane invaginations in PMS. Phase contrast images of a PMS 
incubated with penetratin observed at 10, 45, and 60 minutes after peptide addition (a). Projection of 
confocal slices of a PMS labelled with di-4-ANEPPDHQ before penetratin addition (b). Notice that 
the PMS does not contain membranes in its lumen. Projections of confocal slices of two different PMS 
labelled with di-4-ANEPPDHQ at 50 minutes (c) and 60 minutes (d) after penetratin addition. 
Membrane is green in (c) and yellow in (d) and CF-Pen is blue. Turquoise colour indicates co-
localisation of membrane and peptide (b). Confocal slices of one PMS at 25 minutes (e,f) and 35 
minutes (g,h) after CF-Pen addition. Membrane (red) was labelled with DiI (e,g) and CF-Pen is green 
(f,h). Arrows indicate the co-localisation of membrane and penetratin. Images are representative of 
four (a-d) and two (e-h) independent experiments. Scale bars 10 µm. See also supplementary videos 
S1-4 and supplementary figure S1. 
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Figure 4. Penetratin induced membrane invaginations in PMS are independent of membrane labelling. 
Projections of confocal slices of PMS showing the whole penetratin-induced internal tubular network. 
Unlabelled PMS (a,b) incubated with CF-Pen. PMS labelled with di-4-ANEPPDHQ in green and CF-
Pen in blue (c,d). PMS labelled with DiI in red and CF-Pen in green (e,f). Images are representative of 
two (a,b,e,f) and four (c,d) independent experiments. All images were captured between 70 to 90 
minutes after penetratin incubation. Scale bars 10 µm. See also supplementary videos S1-4. 
 
 
Figure 5. Small arginine rich peptides form tubular invaginations. PMS labelled with di-4-
ANEPPDHQ were incubated with R9 and RW9 peptides. (a) Confocal slice of a PMS after 25 minutes 
of incubation with R9 showing an internal tube (arrow) (see also supplementary video S6). (b) 
Confocal projection of a PMS after 120 minutes of incubation with R9 showing an internal tube 
(arrow) (see also supplementary video S5). The fluorescent saturated mass on the right side of the 
PMS is a rest of the cell that produced the vesicle. (c) Confocal slice of a PMS after 130 minutes of 
incubation with RW9 showing a tube inside the PMS at the left (arrow). Scale bars 10 µm. 
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Figure 6. Model for energy-independent CPP cellular uptake and differences with metabolic 
endocytosis. The first step necessary for physical endocytosis is peptide binding to phospholipids (a). 
Notice that glycan binding of a peptide will result in normal "receptor"-mediated endocytosis. If the 
peptide lacks information to induce negative curvature, phospholipid binding will result also in normal 
endocytosis. The crucial step for physical endocytosis (b, in the box) is the induction of membrane 
curvature driven by the peptide itself without cellular metabolic energy (peptide action is symbolized 
by arrows) local absence (or particular dynamics) of cytoskeleton (crossed lines) will allow the first 
step for membrane invagination.  In normal endocytosis this step is mediated by coating proteins such 
as clathrin and by membrane movements due to the cytoskeleton. The separation of the vesicle from 
the membrane is performed by proteins such as dynamin (x, in c). In PMS the absence of this step 
allows membrane tubulation instead of vesiculation. After fusion of endosomal vesicles with 
endosomes the peptide will translocate into the cytosol thanks to endosome acidification (d). 
 
